Literature DB >> 15017543

The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.

Peter W Dillon1, Robert E Cilley, David Mauger, Christopher Zachary, Andreas Meier.   

Abstract

BACKGROUND/
PURPOSE: Pulmonary hypertension is an integral part of the pathophysiology of the respiratory failure associated with congenital diaphragmatic hernia. Hypothesizing that the evolution of the pulmonary hypertension would determine clinical outcome, the authors examined pulmonary artery pressures in relation to survival in their CDH patients.
METHODS: The authors performed a retrospective chart review of all neonates with the CDH from 1991 to 2002 at their institution eliminating infants with complex congenital heart disease, prematurity, or limited treatment. Cardiac ECHO data were used to estimate pulmonary artery pressures as a ratio to systemic pressure. Statistical analyses of estimated pulmonary pressure ratios stratified by survival status and time were performed using chi2 and Fisher's Exact Test methods.
RESULTS: Forty-seven full-term CDH infants with 428 cardiac ECHO evaluations were studied. Long-term survival rate was 74%. Forty-nine percent of patients had normal pulmonary artery pressure estimates within the first 3 weeks of life. All patients survived. Seventeen percent had persistent systemic or suprasystemic pressure estimates unrelieved by treatment interventions resulting in 100% mortality rate. Thirty-four percent had intermediate reductions in pressure estimates over time with 75% survival rate. Systemic pulmonary artery pressures were associated with decreased survival at all time-points when compared with normal-pressure survivors: week 1, 60% (P <.003); week 3, 38% (P <.007); week 6, 0% (P <.02).
CONCLUSIONS: The evolution of pulmonary hypertension is a critical determinant of survival in CDH patients with current treatment strategies. Three groups can be modeled with markedly different clinical performance patterns. Using serial cardiac ECHO examinations, pulmonary artery pressure estimations can be used to predict clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017543     DOI: 10.1016/j.jpedsurg.2003.11.010

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  41 in total

1.  Sildenafil Use in Children with Pulmonary Hypertension.

Authors:  Jennifer L Cohen; Shannon N Nees; Gerson A Valencia; Erika B Rosenzweig; Usha S Krishnan
Journal:  J Pediatr       Date:  2018-11-02       Impact factor: 4.406

2.  Pulmonary artery size has prognostic value in low birth weight infants with congenital diaphragmatic hernia.

Authors:  Toshiaki Takahashi; Hiroyuki Koga; Toshitaka Tanaka; Hiromichi Shoji; Satoru Takeda; Toshiaki Shimizu; Geoffrey J Lane; Atsuyuki Yamataka; Tadaharu Okazaki
Journal:  Pediatr Surg Int       Date:  2011-04-17       Impact factor: 1.827

3.  Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; David A Partrick; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

4.  Early Left Ventricular Dysfunction and Severe Pulmonary Hypertension Predict Adverse Outcomes in "Low-Risk" Congenital Diaphragmatic Hernia.

Authors:  Duy T Dao; Neil Patel; Matthew T Harting; Kevin P Lally; Pamela A Lally; Terry L Buchmiller
Journal:  Pediatr Crit Care Med       Date:  2020-07       Impact factor: 3.624

5.  Association of high ventilator pressures with the development of chronic pulmonary hypertension in congenital diaphragmatic hernia patients requiring ECMO.

Authors:  Jashodeep Datta; Sharon E Phillips; Edmund Y Yang
Journal:  Pediatr Surg Int       Date:  2012-07-18       Impact factor: 1.827

6.  Effect of corticosteroids and lung ventilation in the VEGF and NO pathways in congenital diaphragmatic hernia in rats.

Authors:  Frances Lilian Lanhellas Gonçalves; Rebeca Lopes Figueira; Ana Leda Bertoncini Simões; Rodrigo Melo Gallindo; Allan Coleman; José Luis Peiró; Lourenço Sbragia
Journal:  Pediatr Surg Int       Date:  2014-10-15       Impact factor: 1.827

7.  Prenatal pulmonary hypertension index: novel prenatal predictor of severe postnatal pulmonary artery hypertension in antenatally diagnosed congenital diaphragmatic hernia.

Authors:  Jose F Vuletin; Foong-Yen Lim; James Cnota; Beth Kline-Fath; Shelia Salisbury; Beth Haberman; Paul Kingma; Jason Frischer; Timothy Crombleholme
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

8.  Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH).

Authors:  Ruth B Seabrook; Theresa R Grover; Natalie Rintoul; Mark Weems; Sarah Keene; Beverly Brozanski; Robert DiGeronimo; Beth Haberman; Holly Hedrick; Jason Gien; Noorjahan Ali; Rachel Chapman; John Daniel; H Allen Harrison; Yvette Johnson; Nicolas F M Porta; Michael Uhing; Isabella Zaniletti; Karna Murthy
Journal:  J Perinatol       Date:  2021-03-01       Impact factor: 2.521

9.  Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; D Dunbar Ivy; Steven H Abman
Journal:  J Pediatr       Date:  2008-10-31       Impact factor: 4.406

10.  Significance of pulmonary artery size and blood flow as a predictor of outcome in congenital diaphragmatic hernia.

Authors:  Tadaharu Okazaki; Manabu Okawada; Satoko Shiyanagi; Hiromichi Shoji; Toshiaki Shimizu; Toshitaka Tanaka; Satoru Takeda; Kazunari Kawashima; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.